Ligands with its PDB code and its tanimoto calculated from the molecule, present in the database, which has for MMscode: MMs02183670
You can sort the columns by Ligand, Ligand name, PDB and Tanimoto.
You can sort the columns by Ligand, Ligand name, PDB and Tanimoto.
| Ligand | Ligand name | Chain | PDB | Tanimoto | Ligand in PDB |
|---|---|---|---|---|---|
| Ligand | Ligand name | Chain | PDB | Tanimoto | Ligand in PDB |
1CA | DESOXYCORTICOSTERONE | A,B | 1Y9R | 0.72 |  |
| 1CA | DESOXYCORTICOSTERONE | A,B,C | 2ABI | 0.72 | |
| 1CA | DESOXYCORTICOSTERONE | A | 2Q3Y | 0.72 | |
| 1CA | DESOXYCORTICOSTERONE | A | 2AA7 | 0.72 | |
PLO | (3BETA)-3-HYDROXYPREGN-5-EN-20- ONE | A | 1Q20 | 0.76 | |
TES | TESTOSTERONE | A | 1JTV | 0.75 | |
| TES | TESTOSTERONE | A | 2Q7L | 0.75 | |
| TES | TESTOSTERONE | A | 2Q7I | 0.75 | |
| TES | TESTOSTERONE | A,B | 1J96 | 0.75 | |
| TES | TESTOSTERONE | A | 2Q7K | 0.75 | |
| TES | TESTOSTERONE | A,B | 1Q13 | 0.75 | |
| TES | TESTOSTERONE | H | 1I9J | 0.75 | |
| TES | TESTOSTERONE | A,B | 1AFS | 0.75 | |
| TES | TESTOSTERONE | H | 1VPO | 0.75 | |
| TES | TESTOSTERONE | A | 2Q7J | 0.75 | |
| TES | TESTOSTERONE | A,B | 3BUR | 0.75 | |
| TES | TESTOSTERONE | A | 2AM9 | 0.75 | |
C0R | CORTICOSTERONE | A | 2A3I | 0.71 | |
| C0R | CORTICOSTERONE | A,B | 1Y5R | 0.71 | |
1NB | 2-(2-HYDROXY-CYCLOPENTYL)-PENT- 4-ENAL | P | 1BRU | 0.75 | |
HEQ | 3-[18-(4-HYDROXY-2,6,6-TRIMETHYL- CYCLOHEX-1-ENYL)-3,7,12,16-TETRAMETHYL- OCTADECA-1,3,5,7,9,11,13,15, 17- NONAENYL]-2,4,4-TRIMETHYL-CYCLOHEX- 2-ENONE | A,B | 1M98 | 0.72 | |
PG2 | PROSTAGLANDIN D2 | A,B | 1RY0 | 0.75 | |
5OP | (5E,13E)-11-HYDROXY-9,15-DIOXOPROSTA- 5,13-DIEN-1-OIC ACID | A | 2ZB4 | 0.77 | |
| 5OP | (5E,13E)-11-HYDROXY-9,15-DIOXOPROSTA- 5,13-DIEN-1-OIC ACID | A,B | 1V3V | 0.77 | |
HYF | 4-HYDROXY-5-ISOBUTYRYL-6-METHYL- 1,3,7-TRIS-(3-METHYL-BUT-2-ENYL)- 6-(4-METHYL-PENT-3-ENYL)-BICYCLO[3.3.1]NON- 3-ENE-2,9-DIONE | A | 1M13 | 0.7 | |
FFA | (10ALPHA,13ALPHA,14BETA,17ALPHA)- 17-HYDROXYANDROST-4-EN-3-ONE | A,B | 2IPG | 0.75 | |
| FFA | (10ALPHA,13ALPHA,14BETA,17ALPHA)- 17-HYDROXYANDROST-4-EN-3-ONE | A,B | 2IPJ | 0.75 | |
| FFA | (10ALPHA,13ALPHA,14BETA,17ALPHA)- 17-HYDROXYANDROST-4-EN-3-ONE | A,B | 2IPF | 0.75 | |
OPD | 9R,13R-12-OXOPHYTODIENOIC ACID | A,B | 1ICQ | 0.75 | |
DL7 | (5beta,14beta,17alpha,25R)-3-oxocholest- 7-en-26-oic acid | A | 3GYU | 0.7 | |
E4H | (3R,4S,5S,7R,9E,11R,12R)-12-ETHYL- 4-HYDROXY-3,5,7,11-TETRAMETHYLOXACYCLODODEC- 9-ENE-2,8-DIONE | A,B | 2HFK | 0.72 | |
AND | 3-BETA-HYDROXY-5-ANDROSTEN-17-ONE | A,B | 1E3R | 0.77 | |
| AND | 3-BETA-HYDROXY-5-ANDROSTEN-17-ONE | A | 3DHE | 0.77 | |
| AND | 3-BETA-HYDROXY-5-ANDROSTEN-17-ONE | A | 1J99 | 0.77 | |
| AND | 3-BETA-HYDROXY-5-ANDROSTEN-17-ONE | A | 1COY | 0.77 | |
| AND | 3-BETA-HYDROXY-5-ANDROSTEN-17-ONE | A | 1Q22 | 0.77 | |
8PG | (8S,12S)-15S-HYDROXY-9-OXOPROSTA- 10Z,13E-DIEN-1-OIC ACID | A,B | 2G5W | 0.75 | |